View in EDS

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Saved in:
Bibliographic Details
Title: The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
Authors: Coukos G; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Gastman BR; Iovance Biotherapeutics, San Carlos, California, USA., Goff SL; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gros A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Harari A; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Hernandez S; University of California San Francisco, San Francisco, California, USA., Ito F; University of Southern California, Los Angeles, California, USA., Maker AV; University of California San Francisco, San Francisco, California, USA., Mullinax JE; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA., Murthy P; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Pai SI; Yale University School of Medicine, New Haven, Connecticut, USA., Prabhakaran S; University of New Mexico, UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA., Restifo NP; Medici Therapeutics, Boston, Massachusetts, USA., Silver NL; Cleveland Clinic, Cleveland, Ohio, USA., Marincola Smith P; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Turcotte S; Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada., Wagner PL; Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA., Yang JC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lotze MT; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Nov 29; Vol. 13 (11). Date of Electronic Publication: 2025 Nov 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41320228
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Coukos+G%22">Coukos G</searchLink>; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Gastman+BR%22">Gastman BR</searchLink>; Iovance Biotherapeutics, San Carlos, California, USA.<br /><searchLink fieldCode="AU" term="%22Goff+SL%22">Goff SL</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gros+A%22">Gros A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Harari+A%22">Harari A</searchLink>; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hernandez+S%22">Hernandez S</searchLink>; University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Ito+F%22">Ito F</searchLink>; University of Southern California, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Maker+AV%22">Maker AV</searchLink>; University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Mullinax+JE%22">Mullinax JE</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Murthy+P%22">Murthy P</searchLink>; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Pai+SI%22">Pai SI</searchLink>; Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Prabhakaran+S%22">Prabhakaran S</searchLink>; University of New Mexico, UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.<br /><searchLink fieldCode="AU" term="%22Restifo+NP%22">Restifo NP</searchLink>; Medici Therapeutics, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Silver+NL%22">Silver NL</searchLink>; Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Marincola+Smith+P%22">Marincola Smith P</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Turcotte+S%22">Turcotte S</searchLink>; Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Wagner+PL%22">Wagner PL</searchLink>; Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Yang+JC%22">Yang JC</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lotze+MT%22">Lotze MT</searchLink>; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Nov 29; Vol. 13 (11). <i>Date of Electronic Publication: </i>2025 Nov 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41320228
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-013420
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Coukos G
      – PersonEntity:
          Name:
            NameFull: Donia M
      – PersonEntity:
          Name:
            NameFull: Gastman BR
      – PersonEntity:
          Name:
            NameFull: Goff SL
      – PersonEntity:
          Name:
            NameFull: Gros A
      – PersonEntity:
          Name:
            NameFull: Harari A
      – PersonEntity:
          Name:
            NameFull: Hernandez S
      – PersonEntity:
          Name:
            NameFull: Ito F
      – PersonEntity:
          Name:
            NameFull: Maker AV
      – PersonEntity:
          Name:
            NameFull: Mullinax JE
      – PersonEntity:
          Name:
            NameFull: Murthy P
      – PersonEntity:
          Name:
            NameFull: Pai SI
      – PersonEntity:
          Name:
            NameFull: Prabhakaran S
      – PersonEntity:
          Name:
            NameFull: Restifo NP
      – PersonEntity:
          Name:
            NameFull: Silver NL
      – PersonEntity:
          Name:
            NameFull: Marincola Smith P
      – PersonEntity:
          Name:
            NameFull: Turcotte S
      – PersonEntity:
          Name:
            NameFull: Wagner PL
      – PersonEntity:
          Name:
            NameFull: Yang JC
      – PersonEntity:
          Name:
            NameFull: Lotze MT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 11
              Text: 2025 Nov 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1